News

Pharmabiz5m

Four drugs for rare diseases to be made available this year, says Dr Vinod Paul

Four drugs for rare diseases approved for manufacturing under the production linked incentive (PLI) scheme for pharmaceuticals under the Department of Pharmaceuticals (DoP) are expected to be ...
Pharmabiz19m

Pharmexcil in talks with stakeholders to launch online logistics platform to streamline logistics operations

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is in talks with the stakeholders to launch an online logistics platform to streamline operations by centralizing services and ...
Pharmabiz19m

Advances in gallbladder surgery are improving outcomes in high-risk patients: Dr Anushtup De

Advances in gallbladder surgery are improving outcomes in high-risk patients: Dr Anushtup De: Shardul Nautiyal, Mumbai Thursday, August 21, 2025, 08:00 Hrs [IST] Advances in gallb ...
Pharmabiz15h

Telangana emerging as global life sciences powerhouse with an investment of over Rs. 54,000 crore since 2024

Our Bureau, Mumbai Wednesday, August 20, 2025, 17:15 Hrs [IST] ...
Pharmabiz14h

US FDA extends review timeline of Regenxbio’s BLA for clemidsogene lanparvovec to treat Mucopolysaccharidosis II

US FDA extends review timeline of Regenxbio’s BLA for clemidsogene lanparvovec to treat Mucopolysaccharidosis II: Rockville, Maryland Wednesday, August 20, 2025, 18:00 Hrs [IST] ...
Pharmabiz16h

China NMPA grants breakthrough therapy designation to Antengene’s ATG-022 to treat gastric/gastroesophageal junction adenocarcinoma

China NMPA grants breakthrough therapy designation to Antengene’s ATG-022 to treat gastric/gastroesophageal junction adenocarcinoma: Shanghai Wednesday, August 20, 2025, 16:00 H ...
Pharmabiz21h

RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries

RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries: Yantai, China Wednesday, August 20, 2025, 11:00 Hr ...
Pharmabiz19h

MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar

MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar: San Diego, California Wednesday, August 20, 2025, 13:00 Hrs [IST] MedImpact Holdings Inc., the largest independen ...
Pharmabiz22h

Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases

Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases: Ingelheim, Germany Wednesday, ...
Pharmabiz20h

Lupin launches bosentan tablets for oral suspension in US with 180-day exclusivity

Lupin launches bosentan tablets for oral suspension in US with 180-day exclusivity: Our Bureau, Mumbai Wednesday, August 20, 2025, 12:20 Hrs [IST] Global pharma major Lupin Limite ...
Pharmabiz17h

Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance

Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...
Pharmabiz18h

PCI Biotech discontinues development of PCL technology and evaluation of future operations

PCI Biotech discontinues development of PCL technology and evaluation of future operations: Oslo, Norway Wednesday, August 20, 2025, 14:00 Hrs [IST] PCI Biotech Holding ASA, a bio ...